THE SCIENCE AND ART OF PROTEAL THERAPY 195 



have been expected, and was in point of fact predicted by me as 

 a probable sequel a prediction of so definite and tangible a char- 

 acter as to have led to the original clincal tests above described, 

 and, sequentially, to the more comprehensive tests that are now 

 under way in various sanitariums and hospitals and in the 

 hands of a large number of private practitioners. 



In an earlier section of this book I have called specific atten- 

 tion to the similarity of the blood conditions in advanced cases 

 of tuberculosis and of cancer. I would reiterate here the not 

 altogether unfamiliar doctrine that the tubercular subject does 

 not as a rule die of direct poisoning by the tubercle germ, but 

 of secondary infection associated with other types of micro-or- 

 ganisms, and with the ultimate development of degenerative 

 protein-product masses in the lungs or elsewhere, partial hydrol- 

 ysis and absorption of which produces a toxaemia strictly com- 

 parable to the toxaemia of malignant neoplasms. 



There was every apriori warrant, therefore, for the prediction 

 that the blood corpuscles might be stimulated by protein therapy 

 to do something toward proteolizing and eliminating from the 

 system the obnoxious protein masses that owed their inception, 

 to be sure, to the original invasion of the tubercle bacillus, but 

 which have now become in effect malignant neoplasms; totally 

 different, assuredly, from the masses usually classified as cancer- 

 ous in their histological structure and in the specific type of 

 irritant associated with their genesis ; yet fundamentally akin to 

 cancer in that their development was conditioned on relative 

 failure of the corpuscular activities, and in their inherent tend- 

 ency to engender progressive exhaustion of the blood-forming 

 mechanism and ultimately to terminate the life of the individual 

 in whose body they develop. 



The analogy of the observed effect of Proteal treatment of 

 cancer, therefore, gives additional support to hopeful prognosti- 

 cations as to the value of the Proteals in tuberculosis, founded 

 theoretically on the Proteomorphic theory and practically on 

 observation of a limited number of very striking cases hitherto 

 subjected to this treatment. By the time my projected book on 

 Proteal Therapy is ready for the press, there is every prospect 

 that a body of evidence will be in hand that will answer unequivo- 

 cally the question as to the ultimate value and the limitations of 

 Proteal Therapy in its application to tuberculosis. 



Meantime, in order to round out this preliminary survey of the 

 present status of the method, we may now turn to a considera- 

 tion of the use of the Proteals in those conditions of blood dis- 

 turbance in which the aetiological factors are so obscure that the 

 blood conditions themselves have taken rank as specific maladies 

 under the name of anaemias and leukaemias ; in the antagonizing 



